Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares yesterday demonstrated remarkable tenacity on the US stock charts. Following a little 0.77% increase to $6.58 during the regular
Aurinia Pharmaceuticals Inc. (AUPH) declined in the pre-market after announcing its fourth quarter and fiscal 2021 results. AUPH values at $13.10, losing more than 20%
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.